Download - WHOCC

QD04AA
Antihistamines for topical use
In each 5th level, antiseptics, siccants etc. may occur in combination with the
antihistamines. Combinations with corticosteroids, see QD07 - Corticosteroids,
dermatological preparations.
QD04AB
Anesthetics for topical use
In each 5th level, antiseptics, siccants etc. may occur in combination with the
anesthetics. Combinations with corticosteroids, see QD07 - Corticosteroids,
dermatological preparations. See also QN01B - Anesthetics, local.
QD04AX
Other antipruritics
Ointments, creams, liniments etc. containing e.g. camphor, menthol and calamine
are classified in this group. When preparations in this group are to be classified,
alternative groups should be considered, e.g.:
QD02 - Emollients and protectives
QD08 - Antiseptics and disinfectants
QM02 - Topical products for joint and muscular pain
QD05
QD05A
DRUGS FOR KERATOSEBORRHEIC DISORDERS (ATC HUMAN:
ANTIPSORIATICS)
DRUGS FOR KERATOSEBORRHEIC DISORDERS, TOPICAL USE (ATC
HUMAN: ANTIPSORIATICS FOR TOPICAL USE)
All corticosteroids for topical use are classified in QD07 - Corticosteroids,
dermatological preparations.
QD05AA
Tars
All tar preparations for dermatological use are classified in this group, except for
combinations with corticosteroids.
QD05AC
QD05AD
QD05AX
Antracen derivatives
Psoralens for topical use
Drugs for keratoseborrheic disorders (ATC human: Other antipsoriatics for topical
use)
QD05B
QD05BA
QD05BB
DRUGS FOR KERATOSEBORRHEIC DISORDERS, SYSTEMIC USE (ATC
HUMAN: ANTIPSORIATICS FOR SYSTEMIC USE)
Psoralens for systemic use
Retinoids for treatment of psoriasis
64